Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 21, 2019 - The FDA announced the approval of SK Biopharmaceuticals’ Xcopri (cenobamate), for the treatment of partial-onset seizures in adult patients.
Return to publications